From: Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
NASH-CHECK scale score | Part B | Part C | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
n | Mean (SD) | Min–Max | Floor, n (%) | Ceiling, n (%) | n | Mean (SD) | Min–Max | Floor, n (%) | Ceiling, n (%) | |
Abdominal Pain | 86 | 0.72 (1.47) | 0.0–7.0 | 60 (69.8) | 0 (0.0) | 149 | 1.26 (1.96) | 0.0–8.0 | 90 (60.4) | 0 (0.0) |
Abdominal Bloating | 86 | 1.55 (2.12) | 0.0–8.0 | 45 (52.3) | 0 (0.0) | 149 | 2.08 (2.62) | 0.0–9.0 | 64 (43.0) | 0 (0.0) |
Fatigue | 86 | 3.06 (2.55) | 0.0–9.0 | 15 (17.4) | 0 (0.0) | 149 | 3.54 (2.99) | 0.0–10.0 | 36 (24.2) | 1 (0.7) |
Sleep | 86 | 1.77 (2.55) | 0.0–9.0 | 40 (46.5) | 0 (0.0) | 149 | 2.66 (2.76) | 0.0–10.0 | 49 (32.9) | 1 (0.7) |
Itchy Skin | 86 | 1.28 (1.97) | 0.0–10.0 | 46 (53.5) | 1 (1.2) | 149 | 1.57 (2.06) | 0.0–9.0 | 67 (45.0) | 0 (0.0) |
Cognitive Symptoms | 86 | 1.38 (1.82) | 0.0–8.0 | 23 (26.7) | 0 (0.0) | 149 | 1.87 (2.16) | 0.0–8.5 | 40 (26.8) | 0 (0.0) |
Activity Limitations | 86 | 1.68 (2.05) | 0.0–7.2 | 27 (31.4) | 0 (0.0) | 149 | 1.67 (1.93) | 0.0–8.8 | 39 (26.2) | 0 (0.0) |
Emotional Impact | 86 | 2.11 (1.66) | 0.0–7.5 | 12 (14.0) | 0 (0.0) | 149 | 2.52 (1.96) | 0.0–8.3 | 16 (10.7) | 0 (0.0) |
Social Impact | 86 | 0.88 (1.40) | 0.0–8.6 | 38 (44.2) | 0 (0.0) | 149 | 1.19 (1.72) | 0.0–7.1 | 76 (51.0) | 0 (0.0) |